Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts

导出原文传递

翻译打印收藏纠错

作者： de Castro, Gilberto, Jr. ^[1] ; Alves, Gustavo V. ^[2] ; Castro, Ana F. ^[3] ; Chaves, Aline L. F. ^[4] ; De Marchi, Pedro ^[5] ; de Oliveira, Thiago B. ^[6] ; Dias, Fernando L. ^[7] ; Guindalini, Rodrigo S. C. ^[8] ; Nicolau, Ulisses R. ^[9] ; Soares, Andrey ; Mora, Paulo A. R.

作者单位： Lenitudes Med Ctr & Res, Santa Maria Feira, Portugal ^[1] Inst Canc Estado Sao Paulo, Ave Doutor Arnaldo 251, BR-01246000 Sao Paulo, SP, Brazil ^[2] AC Camargo Canc Ctr, Sao Paulo, Brazil ^[3] Inst Nacl Canc, Rio De Janeiro, Brazil ^[4] Ctr Paulista Oncol, Sao Paulo, Brazil ^[5] Hosp Canc Barretos, Barretos, Brazil ^[6] Clin CLION, Grp CAM, Salvador, BA, Brazil ^[7] DOM Oncol, Divinopolis, Brazil ^[8] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil ^[9]

关键词 Cetuximab Cisplatin Drug therapy Head and neck neoplasms Platinum analogs Radiotherapy

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Critical reviews in oncology/hematology

2018年131卷

30-34页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts

Critical reviews in oncology/hematology

相似文献

Critical reviews in oncology/hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts

Critical reviews in oncology/hematology

相似文献

Critical reviews in oncology/hematology

相关期刊

检索历史清除